These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36996331)

  • 21. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
    McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction.
    Habert P; Chetrit E; Coiffard B; Bregeon F; Thomas P; Loundou A; Bermudez J; Reynaud-Gaubert M; Gaubert JY
    Insights Imaging; 2023 Sep; 14(1):154. PubMed ID: 37741923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and outcomes of vocal cord paralysis after lung transplantation - a retrospective cohort study.
    Seeliger B; Drick N; Avsar M; Tudorache I; Welte T; Gottlieb J; Greer M
    Transpl Int; 2019 Jun; 32(6):626-634. PubMed ID: 30663812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.
    Allyn PR; Duffy EL; Humphries RM; Injean P; Weigt SS; Saggar R; Shino MY; Lynch JP; Ardehali A; Kubak B; Tseng CH; Belperio JA; Ross DJ; Gregson AL
    Transplantation; 2016 Nov; 100(11):2424-2431. PubMed ID: 27467538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity in pediatric kidney transplant recipients and the risks of acute rejection, graft loss and death.
    Ladhani M; Lade S; Alexander SI; Baur LA; Clayton PA; McDonald S; Craig JC; Wong G
    Pediatr Nephrol; 2017 Aug; 32(8):1443-1450. PubMed ID: 28361229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors analysis for 1-year postoperative survival of patients with benign end-stage lung diseases after lung transplantation].
    Xu H; Wang D; Jiang S; Zhang F; Gao S; Chen G; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jul; 33(7):832-837. PubMed ID: 34412753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 31. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death.
    Meier-Kriesche HU; Arndorfer JA; Kaplan B
    Transplantation; 2002 Jan; 73(1):70-4. PubMed ID: 11792981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
    Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
    Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation.
    Ehrsam JP; Schuurmans MM; Laager M; Opitz I; Inci I
    Transpl Int; 2022; 35():10451. PubMed ID: 35845547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association Between Frailty and Chronic Lung Allograft Dysfunction After Lung Transplantation.
    Singer JP; Gao Y; Huang CY; Kordahl RC; Sriram A; Hays SR; Kukreja J; Venado A; Calabrese DR; Greenland JR
    Transplantation; 2023 Oct; 107(10):2255-2261. PubMed ID: 37287095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and mortality in persons with obstructive lung disease using data from the NHANES III.
    Jordan JG; Mann JR
    South Med J; 2010 Apr; 103(4):323-30. PubMed ID: 20224489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Retrospective Study of Posttransplant Amiodarone Exposition on Clad Development and Survival After Lung Transplantation.
    Magnusson JM; Bobbio E; Danielsson C; Wallinder A; Dellgren G; Bollano E
    Transplant Proc; 2022 Apr; 54(3):789-794. PubMed ID: 35221126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical Risks and Costs of Care are Greater in Patients Who Are Super Obese and Undergoing THA.
    Meller MM; Toossi N; Gonzalez MH; Son MS; Lau EC; Johanson N
    Clin Orthop Relat Res; 2016 Nov; 474(11):2472-2481. PubMed ID: 27562787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year.
    Permpalung N; Liang T; Gopinath S; Bazemore K; Mathew J; Ostrander D; Durand CM; Shoham S; Zhang SX; Marr KA; Avery RK; Shah PD
    J Heart Lung Transplant; 2023 Jul; 42(7):953-963. PubMed ID: 36925381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.
    Saito T; Takahashi H; Kaneda H; Binnie M; Azad S; Sato M; Waddell TK; Cypel M; Liu M; Keshavjee S
    Am J Transplant; 2013 Dec; 13(12):3192-201. PubMed ID: 24164971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.